{"id":33610,"date":"2022-10-26T10:42:16","date_gmt":"2022-10-26T08:42:16","guid":{"rendered":"https:\/\/www.satt.fr\/?p=33610"},"modified":"2022-11-29T09:29:24","modified_gmt":"2022-11-29T08:29:24","slug":"satt-up-octobre-2022","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-octobre-2022\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022"},"content":{"rendered":"<div id=\"pl-33610\"  class=\"panel-layout\" ><div id=\"pg-33610-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Retrouvez les derni\u00e8res actualit\u00e9s des startup accompagn\u00e9es par les membres du R\u00e9seau SATT pour le mois d'octobre 2022 #SATTUP.<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-33610-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Laur\u00e9at de l\u2019EIC Accelerator : Orixha re\u00e7oit 7,5 M\u20ac pour son projet LuncoLive.<\/strong> <em>(Erganeo)<\/em><\/p>\n<p>Orixha annonce que son programme LuncoLive a \u00e9t\u00e9 s\u00e9lectionn\u00e9 par l\u2019European Innovation Council pour un pr\u00eat de 2,45 M\u20ac et un investissement en capital de 5 M\u20ac, afin d\u2019am\u00e9liorer la survie des patients post arr\u00eat cardiaque. Ce financement permettra de valider le b\u00e9n\u00e9fice clinique de la solution Vent2Cool d\u2019Orixha dans le syndrome post arr\u00eat cardiaque et d\u2019optimiser sa technologie de Ventilation Liquidienne pour explorer d\u2019autres applications m\u00e9dicales en Soins Critiques.<\/p>\n<p><a href=\"https:\/\/orixha.com\/\">orixha.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-1-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"2\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-300x118.png\" class=\"image wp-image-33579  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Orixha.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-33610-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"3\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Apmonia Therapeutics annonce un financement de 2,5 M\u20ac pour d\u00e9velopper son principal candidat ciblant les cancers solides.<\/strong> <em>(SATT Nord)<\/em><\/p>\n<p>Apmonia Therapeutics, une soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant de nouvelles strat\u00e9gies th\u00e9rapeutiques bas\u00e9es sur des approches peptidiques, annonce aujourd\u2019hui avoir obtenu un financement non dilutif de 2,5 M\u20ac. Ce nouveau financement s\u2019inscrit majoritairement dans le cadre du dispositif \u00ab Aide au d\u00e9veloppement Deep Tech \u00bb de Bpifrance. En incluant la pr\u00e9c\u00e9dente lev\u00e9e de fonds de 4 M\u20ac annonc\u00e9e en f\u00e9vrier 2022 et les premiers financements obtenus, ce sont au total plus de 8 M\u20ac qui sont mobilis\u00e9s au service du d\u00e9veloppement de la plateforme technologique d\u2019Apmonia Therapeutics.<\/p>\n<p><a href=\"http:\/\/apmonia-therapeutics.com\/\">apmonia-therapeutics.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-2-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"4\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-300x118.png\" class=\"image wp-image-33577  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Apmonia.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-33610-3\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-3-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"5\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>La start-up Green Impulse l\u00e8ve 5 millions d'euros.<\/strong> <em>(Ouest Valorisation)<\/em><\/p>\n<p>La start-up Green Impulse a annonc\u00e9 jeudi 22 septembre 2022 avoir r\u00e9colt\u00e9 5 millions d\u2019euros au cours d\u2019un second tour de table aupr\u00e8s des fonds Ecotechnologies 2 (g\u00e9r\u00e9 par Bpifrance), Go capital, Pays de la Loire D\u00e9veloppement et de la plateforme de financement participatif GwenneG. Green Impulse d\u00e9veloppe et commercialise des solutions dites de \u00ab Biocontr\u00f4le \u00bb permettant de renforcer la protection des plantes face aux pathog\u00e8nes. Cette op\u00e9ration va lui permettre d\u2019acc\u00e9l\u00e9rer son d\u00e9veloppement et sa recherche dans l\u2019objectif de \u00ab participer activement au changement d\u2019un mod\u00e8le agricole qui doit aujourd\u2019hui r\u00e9duire son impact \u00e9cologique et assurer la sant\u00e9 des consommateurs \u00bb, d\u00e9clare Green Impulse.<\/p>\n<p><a href=\"https:\/\/greenimpulse.fr\/\">greenimpulse.fr<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-3-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-3-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"6\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-300x118.png\" class=\"image wp-image-33600  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Green.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-33610-4\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-4-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"7\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Mablink Bioscience annonce un financemenet de s\u00e9rie A de 31 millions d'euros men\u00e9 par Sofinnova Partners et Merieux Equity Partners.<\/strong> <em>(PULSALYS)<\/em><\/p>\n<p>Ce financement permettra \u00e0 la soci\u00e9t\u00e9 de porter son candidat m\u00e9dicament lead en phase clinique et de cr\u00e9er un pipeline d\u2019anticorps conjugu\u00e9s (ADC) de nouvelle g\u00e9n\u00e9ration. Sa plateforme ADC propri\u00e9taire ouvre la voie \u00e0 de nouvelles solutions th\u00e9rapeutiques plus cibl\u00e9es et mieux tol\u00e9r\u00e9es pour les patients atteints de cancer. Cette startup s'appuie sur les r\u00e9sultats issus de l'Institut de Chimie et de Biochimie Mol\u00e9culaires et Supramol\u00e9culaires (ICBMS : Universit\u00e9 Claude Bernard Lyon 1, INSA Lyon, CPE et CNRS) et du Centre de Recherche en Canc\u00e9rologie de Lyon (Universit\u00e9 Claude Bernard Lyon 1, Centre L\u00e9on B\u00e9rard, Inserm et CNRS).<\/p>\n<p><a href=\"https:\/\/www.mablink.com\/\">www.mablink.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-4-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-4-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"8\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-300x118.png\" class=\"image wp-image-33602  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/mablink.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-33610-5\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-5-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-5-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"9\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>VitaDX signe un partenariat strat\u00e9gique avec le groupe XPath pour l\u2019utilisation de sa solution logiciel VisioCyt\u00ae.<\/strong> <em>(SATT Paris-Saclay)<\/em><\/p>\n<p>VitaDX, soci\u00e9t\u00e9 de deeptech en sant\u00e9 \u2013 pionni\u00e8re dans l\u2019utilisation de l\u2019intelligence artificielle et du traitement d\u2019images en cytologie \u2013 annonce sa collaboration avec XPath pour poursuivre le d\u00e9ploiement en France de sa solution VisioCyt\u00ae pour le diagnostic pr\u00e9coce du cancer de la vessie, le 5\u00e8me cancer le plus fr\u00e9quent en France, avec plus de 13.000 nouveaux cas par an.<\/p>\n<p><a href=\"https:\/\/vitadx.com\/node\/3\">vitadx.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-5-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-5-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"10\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-300x118.png\" class=\"image wp-image-33606  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/Vita.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><div id=\"pg-33610-6\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-33610-6-0\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-6-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"11\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>BioMAdvanced Diagnostics l\u00e8ve 1,7 million d\u2019euros pour d\u00e9velopper ses solutions d\u2019aide au diagnostic et am\u00e9liorer la vie des greff\u00e9s du rein et du poumon.<\/strong> <em>(Ouest Valorisation)<\/em><\/p>\n<p>BioMAdvanced Diagnostics, annonce une lev\u00e9e de fonds de 1,7 million d\u2019euros. La startup incub\u00e9e par Atlanpole, et accompagn\u00e9e par la SATT Ouest Valorisation, a re\u00e7u plusieurs prix comme le prix de la R\u00e9gion Pays de la Loire lors de Start West 2021 et la bourse French Tech Emergence de Bpifrance. Spin-off du CR2TI - Centre de Recherche Translationnelle en Transplantation et Immunologie - bas\u00e9 au CHU de Nantes, BioMAdvanced Diagnostics b\u00e9n\u00e9ficie d\u2019une licence exclusive d\u2019exploitation des brevets qui y ont \u00e9t\u00e9 d\u00e9velopp\u00e9s dans le but de mettre \u00e0 disposition des m\u00e9decins des tests d\u2019aide au diagnostic bas\u00e9s sur 20 ans de recherche acad\u00e9mique.<\/p>\n<p><a href=\"https:\/\/www.biomadvanced-diagnostics.com\/\">www.biomadvanced-diagnostics.com<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"pgc-33610-6-1\"  class=\"panel-grid-cell\" ><div id=\"panel-33610-6-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"12\" ><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-300x118.png\" class=\"image wp-image-33575  attachment-medium size-medium\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-300x118.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-150x59.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-768x301.png 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-500x196.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-600x235.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO-200x78.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/10\/BIO.png 972w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Retrouvez les derni\u00e8res actualit\u00e9s des startup accompagn\u00e9es par les membres du R\u00e9seau SATT pour le mois d&#8217;octobre 2022 #SATTUP. Laur\u00e9at de l\u2019EIC Accelerator : Orixha re\u00e7oit 7,5 M\u20ac pour son projet LuncoLive. (Erganeo) Orixha annonce que son programme LuncoLive a \u00e9t\u00e9 s\u00e9lectionn\u00e9 par l\u2019European Innovation Council pour un pr\u00eat de 2,45 M\u20ac et un investissement [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":30125,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[536,603],"tags":[],"class_list":["post-33610","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite","category-startup"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/satt-up-octobre-2022\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022\",\"datePublished\":\"2022-10-26T08:42:16+00:00\",\"dateModified\":\"2022-11-29T08:29:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/\"},\"wordCount\":814,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/SATTUP.png\",\"articleSection\":[\"Actualit\u00e9\",\"Startup\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/SATTUP.png\",\"datePublished\":\"2022-10-26T08:42:16+00:00\",\"dateModified\":\"2022-11-29T08:29:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/SATTUP.png\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/SATTUP.png\",\"width\":3200,\"height\":1785},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/satt-up-octobre-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022","datePublished":"2022-10-26T08:42:16+00:00","dateModified":"2022-11-29T08:29:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/"},"wordCount":814,"image":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","articleSection":["Actualit\u00e9","Startup"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/","url":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/","name":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","datePublished":"2022-10-26T08:42:16+00:00","dateModified":"2022-11-29T08:29:24+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/satt-up-octobre-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2022\/03\/SATTUP.png","width":3200,"height":1785},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/satt-up-octobre-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des startup accompagn\u00e9es par les membres du R\u00e9seau SATT #37 \u2013 Octobre 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/33610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=33610"}],"version-history":[{"count":5,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/33610\/revisions"}],"predecessor-version":[{"id":33886,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/33610\/revisions\/33886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/30125"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=33610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=33610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=33610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}